vs
阿普塔集团（ATR）与NetApp（NTAP）财务数据对比。点击上方公司名可切换其他公司
NetApp的季度营收约是阿普塔集团的1.8倍（$1.7B vs $962.7M），NetApp净利率更高（17.9% vs 7.7%，领先10.2%），阿普塔集团同比增速更快（13.5% vs 2.8%），阿普塔集团自由现金流更多（$96.9M vs $78.0M），过去两年NetApp的营收复合增速更高（3.0% vs 2.6%）
阿普塔集团（AptarGroup, Inc.）是总部位于美国的全球性制造企业，主营消费品分配包装产品及药物给药装置的研发与生产，目前在全球18个国家设有生产运营基地，服务医药、快消等多领域客户。
NetApp是总部位于美国加利福尼亚州圣何塞的企业级数据基础设施服务商，成立于1992年，2012至2021年连续入选《财富》世界500强。公司面向全球企业客户提供统一数据存储、集成数据服务及云运营解决方案，可满足线上线下全场景的应用与数据管理需求。
ATR vs NTAP — 直观对比
营收规模更大
NTAP
是对方的1.8倍
$962.7M
营收增速更快
ATR
高出10.7%
2.8%
净利率更高
NTAP
高出10.2%
7.7%
自由现金流更多
ATR
多$18.9M
$78.0M
两年增速更快
NTAP
近两年复合增速
2.6%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $962.7M | $1.7B |
| 净利润 | $74.3M | $305.0M |
| 毛利率 | — | 72.0% |
| 营业利润率 | 11.0% | 23.4% |
| 净利率 | 7.7% | 17.9% |
| 营收同比 | 13.5% | 2.8% |
| 净利润同比 | -26.4% | 2.0% |
| 每股收益（稀释后） | $1.13 | $1.51 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRNTAP
| Q4 25 | $962.7M | $1.7B | ||
| Q3 25 | $961.1M | $1.6B | ||
| Q2 25 | $966.0M | $1.7B | ||
| Q1 25 | $887.3M | $1.6B | ||
| Q4 24 | $848.1M | $1.7B | ||
| Q3 24 | $909.3M | $1.5B | ||
| Q2 24 | $910.1M | $1.7B | ||
| Q1 24 | $915.4M | $1.6B |
净利润ATRNTAP
| Q4 25 | $74.3M | $305.0M | ||
| Q3 25 | $127.9M | $233.0M | ||
| Q2 25 | $111.7M | $340.0M | ||
| Q1 25 | $78.8M | $299.0M | ||
| Q4 24 | $100.9M | $299.0M | ||
| Q3 24 | $100.0M | $248.0M | ||
| Q2 24 | $90.5M | $291.0M | ||
| Q1 24 | $83.1M | $313.0M |
毛利率ATRNTAP
| Q4 25 | — | 72.0% | ||
| Q3 25 | — | 70.4% | ||
| Q2 25 | — | 68.9% | ||
| Q1 25 | — | 69.8% | ||
| Q4 24 | — | 71.0% | ||
| Q3 24 | — | 71.3% | ||
| Q2 24 | — | 70.5% | ||
| Q1 24 | — | 71.7% |
营业利润率ATRNTAP
| Q4 25 | 11.0% | 23.4% | ||
| Q3 25 | 14.2% | 19.8% | ||
| Q2 25 | 14.9% | 20.1% | ||
| Q1 25 | 12.8% | 22.1% | ||
| Q4 24 | 14.2% | 20.8% | ||
| Q3 24 | 15.2% | 18.3% | ||
| Q2 24 | 13.8% | 21.9% | ||
| Q1 24 | 12.2% | 22.8% |
净利率ATRNTAP
| Q4 25 | 7.7% | 17.9% | ||
| Q3 25 | 13.3% | 14.9% | ||
| Q2 25 | 11.6% | 19.6% | ||
| Q1 25 | 8.9% | 18.2% | ||
| Q4 24 | 11.9% | 18.0% | ||
| Q3 24 | 11.0% | 16.1% | ||
| Q2 24 | 9.9% | 17.4% | ||
| Q1 24 | 9.1% | 19.5% |
每股收益（稀释后）ATRNTAP
| Q4 25 | $1.13 | $1.51 | ||
| Q3 25 | $1.92 | $1.15 | ||
| Q2 25 | $1.67 | $1.64 | ||
| Q1 25 | $1.17 | $1.44 | ||
| Q4 24 | $1.48 | $1.42 | ||
| Q3 24 | $1.48 | $1.17 | ||
| Q2 24 | $1.34 | $1.36 | ||
| Q1 24 | $1.23 | $1.48 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $409.5M | $3.0B |
| 总债务越低越好 | $1.1B | $2.5B |
| 股东权益账面价值 | $2.7B | $986.0M |
| 总资产 | $5.3B | $9.6B |
| 负债/权益比越低杠杆越低 | 0.43× | 2.52× |
8季度趋势，按日历期对齐
现金及短期投资ATRNTAP
| Q4 25 | $409.5M | $3.0B | ||
| Q3 25 | $264.8M | $3.3B | ||
| Q2 25 | $169.8M | $3.8B | ||
| Q1 25 | $136.8M | $2.3B | ||
| Q4 24 | $226.2M | $2.2B | ||
| Q3 24 | $327.9M | $3.0B | ||
| Q2 24 | $223.9M | $3.3B | ||
| Q1 24 | $201.1M | $2.9B |
总债务ATRNTAP
| Q4 25 | $1.1B | $2.5B | ||
| Q3 25 | $546.0M | $2.5B | ||
| Q2 25 | $535.1M | $3.2B | ||
| Q1 25 | $561.2M | $2.0B | ||
| Q4 24 | $688.1M | $2.0B | ||
| Q3 24 | $822.7M | $2.4B | ||
| Q2 24 | $681.5M | $2.4B | ||
| Q1 24 | $680.4M | $2.4B |
股东权益ATRNTAP
| Q4 25 | $2.7B | $986.0M | ||
| Q3 25 | $2.8B | $975.0M | ||
| Q2 25 | $2.7B | $1.0B | ||
| Q1 25 | $2.5B | $995.0M | ||
| Q4 24 | $2.5B | $892.0M | ||
| Q3 24 | $2.5B | $929.0M | ||
| Q2 24 | $2.4B | $1.1B | ||
| Q1 24 | $2.3B | $994.0M |
总资产ATRNTAP
| Q4 25 | $5.3B | $9.6B | ||
| Q3 25 | $5.1B | $9.7B | ||
| Q2 25 | $4.9B | $10.8B | ||
| Q1 25 | $4.5B | $9.0B | ||
| Q4 24 | $4.4B | $9.0B | ||
| Q3 24 | $4.6B | $9.3B | ||
| Q2 24 | $4.5B | $9.9B | ||
| Q1 24 | $4.4B | $9.4B |
负债/权益比ATRNTAP
| Q4 25 | 0.43× | 2.52× | ||
| Q3 25 | 0.20× | 2.55× | ||
| Q2 25 | 0.20× | 3.11× | ||
| Q1 25 | 0.22× | 2.00× | ||
| Q4 24 | 0.28× | 2.23× | ||
| Q3 24 | 0.32× | 2.58× | ||
| Q2 24 | 0.28× | 2.09× | ||
| Q1 24 | 0.29× | 2.41× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $183.7M | $127.0M |
| 自由现金流经营现金流 - 资本支出 | $96.9M | $78.0M |
| 自由现金流率自由现金流/营收 | 10.1% | 4.6% |
| 资本支出强度资本支出/营收 | 9.0% | 2.9% |
| 现金转化率经营现金流/净利润 | 2.47× | 0.42× |
| 过去12个月自由现金流最近4个季度 | $299.6M | — |
8季度趋势，按日历期对齐
经营现金流ATRNTAP
| Q4 25 | $183.7M | $127.0M | ||
| Q3 25 | $177.6M | $673.0M | ||
| Q2 25 | $126.0M | — | ||
| Q1 25 | $82.7M | $385.0M | ||
| Q4 24 | $178.2M | — | ||
| Q3 24 | $229.3M | $341.0M | ||
| Q2 24 | $143.6M | $613.0M | ||
| Q1 24 | $92.3M | $484.0M |
自由现金流ATRNTAP
| Q4 25 | $96.9M | $78.0M | ||
| Q3 25 | $114.3M | $620.0M | ||
| Q2 25 | $62.5M | — | ||
| Q1 25 | $25.9M | $338.0M | ||
| Q4 24 | $112.2M | — | ||
| Q3 24 | $162.7M | $300.0M | ||
| Q2 24 | $75.4M | $567.0M | ||
| Q1 24 | $16.7M | $448.0M |
自由现金流率ATRNTAP
| Q4 25 | 10.1% | 4.6% | ||
| Q3 25 | 11.9% | 39.8% | ||
| Q2 25 | 6.5% | — | ||
| Q1 25 | 2.9% | 20.6% | ||
| Q4 24 | 13.2% | — | ||
| Q3 24 | 17.9% | 19.5% | ||
| Q2 24 | 8.3% | 34.0% | ||
| Q1 24 | 1.8% | 27.9% |
资本支出强度ATRNTAP
| Q4 25 | 9.0% | 2.9% | ||
| Q3 25 | 6.6% | 3.4% | ||
| Q2 25 | 6.6% | — | ||
| Q1 25 | 6.4% | 2.9% | ||
| Q4 24 | 7.8% | — | ||
| Q3 24 | 7.3% | 2.7% | ||
| Q2 24 | 7.5% | 2.8% | ||
| Q1 24 | 8.3% | 2.2% |
现金转化率ATRNTAP
| Q4 25 | 2.47× | 0.42× | ||
| Q3 25 | 1.39× | 2.89× | ||
| Q2 25 | 1.13× | — | ||
| Q1 25 | 1.05× | 1.29× | ||
| Q4 24 | 1.77× | — | ||
| Q3 24 | 2.29× | 1.38× | ||
| Q2 24 | 1.59× | 2.11× | ||
| Q1 24 | 1.11× | 1.55× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
NTAP
| Products | $788.0M | 46% |
| Support | $647.0M | 38% |
| Public Cloud Segment | $171.0M | 10% |
| Professional And Other Services | $99.0M | 6% |
